Search Results - "Discacciati, A"

Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies by Discacciati, A., Orsini, N., Wolk, A.

“…The relationship between obesity and risk of prostate cancer (PCa) is unclear; however, etiologic heterogeneity by subtype of PCa (localized, advanced) related…”
Get full text

Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose–response meta-analysis by Discacciati, A., Orsini, N., Wolk, A.

“…Existing epidemiological evidence is controversial regarding the possible associations between coffee consumption and risk of prostate cancer (PCa) by…”
Get full text

Risk factors and outcomes of chronic opioid use following trauma by von Oelreich, E, Eriksson, M, Brattström, O, Sjölund, K-F, Discacciati, A, Larsson, E, Oldner, A

“…Abstract Background The growing problem of opioid misuse has become a serious crisis in many countries. The role of trauma as a gateway to opioid use is…”
Get full text

Multiplex blood-test and Magnetic Resonance Imaging (MRI) for prostate cancer screening: Results from the 2nd screening round in the STHLM3-MRI trial by Discacciati, A., Abbadi, A., Chandra, J., Annerstedt, M., Glaessgen, A., Carlsson, S., Jäderling, F., Grönberg, H., Eklund, M., Nordström, T.

Get full text

Can we reduce unnecessary prostate biopsies in patients with PI-RADS 3 lesions? Role of PSA density and the Stockholm 3 test by Abbadi, A., Eklund, M., Lantz, A., Discacciati, A., Chandra Engel, J., Björnebo, L., Falagario, U.G., Grönberg, H., Nordström, T.

Get full text

Incidence and lifetime risk of hospitalization and surgery for diverticular disease by Sköldberg, F., Granlund, J., Discacciati, A., Hjern, F., Schmidt, P. T., Olén, O.

“…Background Studies on incidence rates of first‐time colonic diverticular disease are few, and population‐based estimates of lifetime risk are lacking. In this…”
Get full text

Prostate cancer screening: A novel risk prediction tool with standard biopsies vs. PSA with MRI-targeted biopsies by Björnebo, L., Discacciati, A., Eklund, M., Grönberg, H., Lantz, A., Nordström, T.

Get full text

Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening by Eklund, M, Jaderling, F, Discacciati, A, Bergman, M, Annerstedt, M, Aly, M, Glaessgen, A, Carlsson, S, Gronberg, H, Nordstrom, T

Get full text

Long-term effects of 5α-reductase inhibitors on prostate cancer mortality: A large population-based prospective study by Björnebo, L., Nordström, T., Discacciati, A., Palsdottir, T., Aly, M., Grönberg, H., Eklund, M., Lantz, A.

Get full text

The Stockholm3 prostate cancer screening trial (STHLM3): An interim analysis of mortality results after 6.5 years of follow-up by Micoli, C., Crippa, A., Discacciati, A., Vigneswaran, H., Palsdottir, T., Clements, M., Aly, M., Adolfsson, J., Fredrik, W., Wiklund, P., James, T., Lindberg, J., Grönberg, H., Egevad, L., Nordström, T., Eklund, M.

Get full text

MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial by Eklund, M., Jäderling, F., Discacciati, A., Bergman, M., Annerstedt, M., Aly, M., Glaessgen, A., Carlsson, S., Grönberg, H., Nordström, T.

Get full text

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial by Nordström, T., Discacciati, A., Bergman, M., Aly, M., Annerstedt, M., Glaessgen, A., Carlsson, S., Jäderling, F., Eklund, M., Grönberg, H.

Get full text

Stockholm3 validation in a multi-Ethnic cohort for ProsTAte cancer (SEPTA) detection: A multicentered, prospective trial by Vigneswaran, H.T., Eklund, M., Discacciati, A., Nordström, T., Hubbard, R.A., Perlis, N., Abern, M., Moreira, D., Eggener, S., Yonover, P., Chow, A., Watts, K., Liss, M., Thoreson, G., Abreu, A.L., Sonn, G.A., Palsdottir, T., Plym, A., Wiklund, F., Grönberg, H., Murphy, A.B.

Get full text

Author response to: Risk factors and outcomes of chronic opioid use following trauma by von Oelreich, E, Eriksson, M, Brattström, O, Sjölund, K-F, Discacciati, A, Larsson, E, Oldner, A

Get full text

All‐cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism by Giesecke, P., Frykman, V., Wallin, G., Lönn, S., Discacciati, A., Törring, O., Rosenqvist, M.

“…Background Little is known about the long‐term side‐effects of different treatments for hyperthyroidism. The few studies previously published on the subject…”
Get full text

Letter: coffee consumption and gallstone disease – a cautionary note on the assignment of exposure values in dose–response meta‐analyses by Crippa, A., Discacciati, A., Orsini, N., Oskarsson, V.

Get full text

Re: Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis by Discacciati, A, Orsini, N

Get full text

Abdominal obesity associates to incident atherosclerotic cardiovascular disease after myocardial infarction by Mohammadi, H., Ohm, J., Discacciati, A., Sundström, Johan, Hambraeus, K., Jernberg, T., Svensson, P.

Get full text

Increased risk for tooth extraction in primary hyperparathyroidism and hypercalcemia: a population study by Koman, A., Näsman, P., Discacciati, A., Ekbom, A., Nilsson, I-L., Sandborgh-Englund, G.

“…The aim of this study was to analyze dental comorbidities in untreated primary hyperparathyroidism (pHPT). Patients with pHPT subjected to parathyroidectomy…”
Get full text

Low density lipoprotein cholesterol levels at first follow-up after acute myocardial infarction predicts recurrent atherosclerotic cardiovascular disease events poorly by Ohm, J., Hjemdahl, P., Discacciati, A., Hambraeus, K., Jernberg, T., Skoglund, P. H., Sundström, Johan, Svensson, P.

Get full text